Floatz logo

Enclomiphene

Secondary Hypogonadism

Repros Therapeutics Inc.Small moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Secondary Hypogonadism cohort.

Asset / SponsorPhaseRating
TESTOSTERONE UNDECYLATE
Canisius-Wilhelmina Hospital
Phase 4A
Metformin
University Medical Centre Ljubljana
Phase 4BBB
Arimidex
Baylor College of Medicine
Phase 4BBB
Liraglutide
University Medical Centre Ljubljana
Phase 4BB
Testim
Odense University Hospital
Phase 4BB

View all 24 →

Same molecule, other indications

Enclomiphene is also rated in:

hypogonadotropic hypogonadismDormant
B
Indicative ·
57 / 100
View asset →
obesity disorderDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →